BDBM402066 N-{2-[(4,6-dimethylpyrimidin-2- yl)(methyl)amino]ethyl}-N-ethyl-2- (1H-pyrazol-1-yl)pyridine-3- carboxamide::US10011595, B-24

SMILES CCN(CCN(C)c1nc(C)cc(C)n1)C(=O)c1cccnc1-n1cccn1

InChI Key InChIKey=UBMCISCOTUHCMN-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 402066   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM402066(US10011595, B-24 | N-{2-[(4,6-dimethylpyrimidin-2-...)
Affinity DataIC50: 12.8nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM402066(US10011595, B-24 | N-{2-[(4,6-dimethylpyrimidin-2-...)
Affinity DataIC50: 5.08E+3nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
Go to US Patent